Evidence map›Paper›PMID 18981443›Full record

ReviewCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2008

Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia.

David B Hogan, Peter Bailey, Sandra Black, Anne Carswell, Howard Chertkow, Barry Clarke, Carole Cohen, John D Fisk, Dorothy Forbes, Malcolm Man-Son-Hing and 3 more

Abstract readConsensus StatementReview
In one paragraph

Review in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Exercise programs for people with dementia.The Cochrane database of systematic reviews · 2015
    Pooled it
  4. Pooled it
  5. Alzheimer's disease dementia guidelines for diagnostic testing: a systematic review.American journal of Alzheimer's disease and other dementias · 2013
    Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

David B HoganDepartment of Clinical Neurosciences, Health Sciences Centre, University of Calgary, 3330 Hospital Dr. NW, Calgary, ABT2N4N1. dhogan@ucalgary.ca
Peter Bailey
Sandra Black
Anne Carswell
Howard Chertkow
Barry Clarke
Carole Cohen
John D Fisk
Dorothy Forbes
Malcolm Man-Son-Hing
Krista Lanctôt
Debra Morgan
Lilian Thorpe

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPractising physicians frequently seek advice on the most effective interventions for dementia. In this article, we provide practical guidance on nonpharmacologic and pharmacologic interventions for the management of mild to moderate dementia based on recommendations from the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia.

methodsWe developed evidence-based guidelines using systematic literature searches, with specific criteria for the selection and quality assessment of articles, and a clear and transparent decision-making process. We selected articles published from January 1996 to December 2005 that dealt with the management of mild to moderate stages of Alzheimer disease and other forms of dementia. Recommendations based on the literature review were drafted and voted on. Consensus required 80% or more agreement by participants. Subsequent to the conference, we searched for additional articles published from January 2006 to April 2008 using the same major keywords and secondary search terms. We graded the strength of the evidence using the criteria of the Canadian Task Force on Preventive Health Care.

resultsWe identified 1615 articles, of which 954 were selected for further study. From a synthesis of the evidence in these studies, we made 48 recommendations for the management of mild to moderate dementia (28) and dementia with a cerebrovascular component (8) as well as recommendations for addressing ethical issues (e.g., disclosure of the diagnosis) (12). The updated literature review did not change these recommendations. An exercise program is recommended for patients with mild to moderate dementia. Physicians should decide whether to prescribe a cholinesterase inhibitor on an individual basis, balancing anticipated benefits with the potential for harm. For mild mood and behavioural concerns, nonpharmacologic approaches should be considered first.

interpretationAlthough the available therapies for dementia can help with the management of symptoms, there is a need to develop more effective interventions.

Indexed as

AnxietyCholinesterase InhibitorsDementiaDependency, PsychologicalDepressionDopamine AgentsEvidence-Based MedicineExerciseHumansMemantineNeuropsychological TestsOccupational TherapyPractice Guidelines as TopicSeverity of Illness IndexSleep Initiation and Maintenance DisordersCholinesterase InhibitorsDopamine AgentsMemantine

Identifiers

PMID18981443
PMCPMC2572644

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.